Received Sep 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
suffered with Covid, with symptoms; suffered with Covid, with symptoms; This is a spontaneous report received from a Consumer or other non HCP. A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "suffered with Covid, with symptoms". Clinical course: The patient informed that during the Covid pandemic, his wife and himself both received Pfizer's Covid vaccines and boosters. Since Jul of approximately 2023, his wife has suffered the loss of her taste buds. Several medical professionals have suggested that she may have had Covid without symptoms. Later in 2023, approximately Oct, they both suffered with Covid, with symptoms. The loss of her taste buds proceeded her experience with Covid. The patient wanted to know if Pfizer has been notified or experienced any other individuals or groups that have experienced loss of taste with exposure to Pfizer's vaccines and boosters. If yes, what has been the outcome of those experiences and if Pfizer offer any possible cure for the situation his wife was currently experiencing. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 will be requested and submitted if and when received.